Supplement advertising bill
This article was originally published in The Tan Sheet
Executive Summary
Legislation that would allow the same claims permitted in dietary supplement product labeling to appear in consumer advertising introduced by Sen. Michael Crapo (R-Idaho) Oct. 19. The Dietary Supplement Fairness in Labeling and Advertising Act (S 1749) is similar to the bill Crapo introduced last session while a member of the House (1"The Tan Sheet" Oct. 5, 1998, p. 8). The new version, however, also would make FDA rescind its April 29 proposed rule on what constitutes an acceptable structure/function claim. In floor comments made when introducing the bill, Crapo stated that, with the proposal, FDA was "asserting responsibilities beyond congressional intent." The bill has been referred to the Senate Health, Education, Labor & Pensions Committee
You may also be interested in...
Structure/Function Claims In Ads Would Be Allowed Under House Bill
A bill proposing structure/function claims deemed acceptable for dietary supplement labeling also be allowable for dietary supplement advertising was introduced Sept. 16 on the House floor by Rep. Michael Crapo (R-Idaho).
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands